1 edition of Economic costs, cost-effectiveness, financing, and community-based drug treatment found in the catalog.
Economic costs, cost-effectiveness, financing, and community-based drug treatment
by U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse, For sale by the Supt. of Docs., U.S. G.P.O. in Rockville, MD, Washington, DC
Written in English
|Statement||editors: William S. Cartwright, James M. Kaple.|
|Series||NIDA research monograph -- 113., DHHS publication -- ADM 91-1823.|
|Contributions||Cartwright, William S., Kaple, James M., National Institute on Drug Abuse.|
|The Physical Object|
|Pagination||iv, 221 p. :|
|Number of Pages||221|
Read Economic Costs of Cancer Health Disparities: Summary of Meeting Proceedings, by National Cancer Institute. in HTML for FREE. Also available in PDF, ePub and Kindle formats. HTML version, page 5. Chapter 31 provides a concise overview of advances made in recent years in treating these conditions (as well as panic disorder), summarizes information on their burden, and develops estimates of the cost-effectiveness of drug-based and cognitive behavioral therapies in different settings (hospital based and community based).
Part 1: Drug Prohibition and the Abstinence Paradigm. Chapter 1: The Drug Treatment System in the United States: A Panacea for the Drug War? Chapter 2: The Treatment of Drug-Related Problems in Canada: Controlling, Caring, and Curing Chapter 3: Expansion and Implosion: The Story of Drug Treatment in Sweden Chapter 4: Finland: Drug Treatment at the Margins. Title: Economics of Prevention and Treatment Services for Drug and Alcohol Abuse (R01) Announcement Type This is a reissue of PA, which was previously released Update: The following update relating to this announcement has been issued: June 6, - This PA has been reissued as (PA).
Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain Following publication of the original article , the authors reported that one of the numbers within Fig. 6 contains a mistake. Expertise. Health economics, cost-effectiveness analysis, cost-benefit analysis, health financing in the United States and globally. Topics of application include respiratory syncytial virus (RSV), drug and alcohol abuse, cardiovascular disease, dengue, vector control, lymphatic filariasis, malaria, homelessness, oral health, and technology assessment.
Bolte by Bolte
cure of amœbic dysentery
Characteristic eddy decomposition of turbulence in a channel
tapestry of grace
A state of the national debt, as it stood December the 24th, 1716
Lead in food
The slaw and the slow cooked
The story of Horace
Biological variation of markers of cardiac damage
Words and their use.
Scotland illustrated in a series of views taken expressly for this work by T. Allom, W.H. Bartlett, and H. MCulloch
exhibition of paintings.
Economic Costs, Cost-Effectiveness, FInancing, and Community-Based Drug Treatment. National Institute on Drug Abuse Research Monograph on *FREE* shipping on qualifying offers.
Economic Costs, Cost-Effectiveness, FInancing, and Community-Based Drug Treatment. National Institute on Drug Abuse Research Monograph Manufacturer: Unknown.
Economic costs, cost-effectiveness, financing, and community-based drug treatment. Rockville, MD ( Fishers Lane, Rockville ): U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse, (OCoLC) Material Type.
Economic costs, cost-effectiveness, financing, and community-based drug treatment. Rockville, MD ( Fishers Lane, Rockville ): U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse, (DLC) (OCoLC) Material Type.
Drug abuse has been called the nation's number one public health problem (Institute financing Health Policy, ). One of every $12 of the nation's personal health care expenditures is spent on prevention, diagnosis, and treatment of people suffering from addictive diseases.
Illicit drugs, such as. Author(s): Cartwright,William S; Kaple,James M; National Institute on Drug Abuse. Title(s): Economic costs, cost-effectiveness, financing, and community-based drug treatment/ editors, William S. Cartwright, James M. Kaple.
and prospects / Henrick J. Harwood -- Evaluating the cost-effectiveness of drug abuse treatment services / Robert. NIDA Research Monograph Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment. Rockville, MD: National Institute on Drug Abuse.
Courtwright D, Joseph H, Des Jarlais D. Addicts Who Survived: An Oral History of Narcotic Use in America, Knoxville, TN: The University of Tennessee Press.
Apsler, R. Evaluating the cost-effectiveness of drug abuse treatment services. InEconomic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment, National Institute of Drug Abuse Research Monograph SeriesU.S.
Department of Health and Human Services, Rockville, MD, pp. 57– Google ScholarCited by: NIDA Research Monograph: Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment NCBI: Updated Estimates and Cost Bands for Program Assessment and Reimbursement NIH: Principles of Drug Addiction Treatment: A Research-Based Guide NIH: Treatment Approaches for Drug Addiction.
Author(s): Cartwight,W S; Kaple,J M; United States. National Institute on Drug Abuse. Title(s): Economic costs, cost effectiveness, financing, and community based. Treatment services in two national studies of community-based drug abuse treatment programs.
Journal of Substance Abuse, 7, 9– PubMed CrossRef Google ScholarCited by: 3. Benefits and Costs of a Family Focused Methadone Treatment and Drug Abuse Prevention Program: Preliminary Findings Article (PDF Available) January.
Although community-based tobacco dependence treatment cost-effectiveness estimates in our review align with previous clinical findings and findings of nonrandomized controlled studies, more research is needed before definitive comparisons can be made.
Treatment for tobacco use is considered the gold standard of health care cost-effectiveness (30).Author: Sarah A. Reisinger, Sahar Kamel, Eric Seiber, Elizabeth G.
Klein, Electra D. Paskett, Mary Ellen Wew. "New Perspectives on the Benefit-Cost and Cost-Effectiveness of Drug Abuse Treatment." Pp. in Economic Costs, Cost-Effectiveness, Financing. The new costs associated with the community-based treatment to the public sector were small in comparison with the cost of DOT in public clinics.
The incentive paid to community treatment supporters (on average US$ per visit) was much lower than the average cost of a clinic visit (on average US$ per visit). The Drug Abuse Treatment Costs Analysis Program (DATCAP) is based on standard economic principles and the method has recently been tested in two drug abuse intervention studies.
Findings from case studied at three treatment programmes are presented to demonstrate the feasibility and reliability of the instrument.
The cost of a 1-month supply of each drug was determined from the Drug Topics Red Book average wholesale price. 18 This cost was multiplied by 6 (6 months of drugs) and added to the other 6-month cost to determine the annual cost for each drug. A total annual cost of all cardiac, hypertensive, lipid-lowering, and diabetes drugs was.
Economic Costs of Illicit Drugs: Commentary and Critique. Economic Costs, Cost-Effectiveness, and Financing of Community Based Drug Treatment, National Institute on Drug Abuse Research Monograph Series.
; 33– Mullahy J and Sindelar JL. Gender Differences in Labor Market Effects of Alcoholism. Title: Economics of Prevention and Treatment Services for Drug and Alcohol Abuse (R03) Announcement Type This is a modification of PA, which was previously releasedand now is divided into separate Funding Opportunity Announcements (FOAs) for R03, R21, and R01 grant mechanisms.
Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment, Research Monograph SeriesNational Institute on Drug Abuse, Rockville, MD () Google Scholar Tabbush, Cited by: This guide provides practical advice to help program managers and evaluators understand, design, and perform cost-effectiveness (CE) evaluations of community public health prevention programs.
Each chapter of the guide provides advice for addressing specific components of a CE analysis. The guide focuses on common concerns about how best to design and perform CE. Data inputs for universal public finance of tuberculosis treatment in India All the parameters and sources are listed in Tables 1 and 2.
We assume an average incidence of p 0 = perper year (for sputum smear‐positive [ss+] TB cases 9 By virtue of recommending smear microscopy, DOTS focuses on the detection of ss+ TB by: •a comparison of the costs and benefits between treatment and prevention activi-ties •a comparison of the costs and benefits between treatment and law enforcement activities Economic evaluations differ according to their scope and intent.
They can have a very narrow focus, whereby evaluators are only concerned about the resource conse. Targeted Therapeutic options for Lung Cancer Treatment include: bevacizumab, Erlotinib and Crizotinib that the cost-effectiveness of this type of therapies in the treatment of lung cancer has been demonstrated in many studies [52,53,54,55,56,57].
Thus, this therapy can be one of the options for decision makers and politicians to choose and use Cited by: 8.